
Enterome
Developer of pharmaceuticals and diagnostic tests designed for developing off-the-shelf, transformational cancer treatments targeting all tumor types. The company's approach generates a powerful, long...
Valuation
$0
Share Price
N/A
Total Raised
$292.3M
Last Round
N/A